PFE

#98
Pfizer, Inc. Common Stock
26.1 8 USD
+0.46%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
26.07
26.22
Rango anual
23.06
28.75
Cambio diario
+0.46%
Variación mensual
-0.80%
Variación en los últimos 6 meses
+1.63%
Cambio anual
+11.40%
Cierres anteriores
26.0 6
Open
26.1 0
Mínimo
26.0 7
High
26.2 2
Volumen
7 045
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 149.21 B
  • Employee 75 K
  • Founded N/A
  • CEO Albert Bourla
  • Website www.pfizer.com
  • Headquarter Delaware, United States
  • FIGI BBG000BR2B91
  • Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
21.2
Relación precio/flujo de caja
2.51
Dividendos por acción
—
Rendimiento por dividendo, %
9.29

Pfizer, Inc. Common Stock

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America. Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis, Prevnar, Paxlovid, Vyndaqel, Comirnaty, and Ibrance. In 2024, 61% of the company's revenues came from the United States, 4% came from China, and 35% came from other countries. The company is ranked fifth on the list of largest biomedical companies by revenue. It is ranked the 69th on the Fortune 500 and 73rd on the Forbes Global 2000.

Noticias